Sponsor:OrphazymeBrief Summary: A multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of arimoclomol in amyotropic…
Sponsor:BiogenBrief Summary: The primary objective of this study is to evaluate the safety and tolerability of BIIB078 in adults with…
Sponsor:OrphazymeBrief Summary: A multicenter, non-randomized, open label trial, to assess long term safety and efficacy of Arimoclomol in subjects with…
Sponsor:BiogenBrief Summary: The primary objective of this study is to evaluate the safety, tolerability of single-ascending doses of BIIB100 in…
Sponsor:Powell Mansfield Inc.Brief Summary: This is a pilot study to examine the diagnostic utility of a novel transmembrane surface sensor,…
Sponsor:MediciNovaBrief Summary: A Phase 2b/3 multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety and tolerability of…
Sponsor:Leigh R. Hochberg, MD, PhD.Brief Summary: The purpose of this study is to obtain preliminary device safety information and demonstrate…
Sponsor:Loma Linda UniversityBrief Summary: This study is being conducted to help the investigators better understand how the new FDA approved…
Sponsor:University of Kansas Medical CenterBrief Summary: The purpose of this study is to determine if memantine at 20 mg BID…
Sponsor:ProgenaBiomeBrief Summary: This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding…
